New Magnetic Microrobotic Control System From University of Essex Promises to Revolutionize Targeted Cancer Therapy Precision

University of Essex researchers unveil a magnetic control tool to guide microrobots for precise cancer treatment and minimally invasive surgery.

By: AXL Media

Published: Apr 29, 2026, 7:25 AM EDT

Source: Information for this report was sourced from EurekAlert!

Engineering a New Era of Targeted Medical Intervention

A significant breakthrough in medical engineering has emerged from the University of Essex, where researchers have unveiled a specialized magnetic tool designed to navigate tiny robots through the human anatomy. Developed within the Robotics for Under Millimetre Innovation Lab, this technology aims to transform delicate medical procedures into minimally invasive operations. By providing a reliable method for steering miniature devices, the system paves the way for a future where surgeries and drug deliveries are performed with microscopic precision, far beyond the reach of traditional surgical instruments.

The Functional Mechanics of Tuneable Magnetic Control

At the heart of this innovation is the Tuneable Magnetic End Effector, a device capable of switching, shaping, and redirecting magnetic fields with high granularity. Unlike many existing systems that require continuous electrical power to maintain a magnetic pull, this new tool utilizes permanent magnets that can be physically manipulated to adjust the field. This design choice makes the entire apparatus more energy-efficient and compact, which is a critical requirement for integration into sensitive clinical environments where space and safety are paramount.

Mitigating Chemotherapy Risks Through Precision Delivery

Dr. Ali Hoshiar, the head of the RUMI Lab, emphasized that this microrobotic approach offers a more sustainable route for treating diseases like cancer. Current therapies often damage healthy tissue because they circulate throughout the entire body to reach a specific site. However, the new magnetic system allows for the transport of therapeutic agents directly to diseased cells. By concentrating the treatment only where it is needed, clinicians can significantly reduce the debilitating side effects that often accompany aggressive cancer treatments, improving the overall quality of life for patients.